Phenotypic and Functional Profile of Peripheral Blood Lymphomonocytes in Seborrheic Dermatitis.
NCT ID: NCT07297446
Last Updated: 2025-12-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2024-06-19
2025-06-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Seborrheic dermatitis is a chronic-relapsing inflammatory skin disease, common in infancy, puberty, and adulthood (40-60 years). Its multifactorial etiology involves:
Sebaceous gland hyperactivity and altered lipid composition promoting Malassezia proliferation;
Metabolic activation of sebaceous glands by Malassezia, which generates irritating fatty acids;
Immune dysregulation, influencing keratinocyte activation and differentiation;
Barrier disruption, clinically resulting in erythema, scaling, and pruritus.
Previous research on immune cells in barrier tissues (gut, lung, skin) suggests that environmental factors-particularly dietary fatty acids and salt intake-modulate the functional polarization of Th17 vs. Treg cells, with implications for autoimmunity. Tissue-resident memory T cells (TRM), abundant in barrier organs, display site-specific homing markers such as CCR4, CCR10, CXCR4, GATA6, and BCL6. In contrast, circulating TEM and TEMRA subsets share common profiles across tissues.
Protocollo\_Profilo fenotipico e…
In skin, Th17 cells exhibit variable transcriptional states that may reflect tissue-dependent functional states rather than fixed subtypes. Studies in SD have mainly focused on cutaneous immune responses, highlighting roles for Tγδ cells, cytokines (IL-1α, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12, IL-17, TNF-α), and β-defensins, linked to dendritic-cell maturation driven by sebaceous lipids and activation of the NLRP3 inflammasome. Malassezia can also induce IL-1β release from dendritic cells in vitro. However, little is known about how SD affects circulating immune cells or how dietary patterns influence systemic immune responses in this disease.
Study population
The study will include 15 SD patients and 15 non-affected (NA) controls, aged 45-75 years, of both sexes. SD patients must have mild-to-moderate facial involvement and must have stopped topical or systemic treatments for at least two weeks. Exclusion criteria include other skin diseases, neurodegenerative disorders, immunosuppression, ongoing treatments, or HIV positivity. Controls are selected from IFO staff, relatives, and individuals undergoing routine dermatologic examinations.
Methods
After overnight fasting, participants undergo venous blood sampling (7 mL). Plasma is separated and stored at -80°C for secretory and lipidomic profiling. Lymphomonocytes are isolated using Ficoll-Hypaque gradients and analyzed by flow cytometry to characterize immunological phenotypes. Each participant completes a dietary questionnaire at enrollment. Collected data include demographics, clinical history, dietary information, laboratory findings, and SD-specific clinical data (for the patient group).
Statistical plan
As a pilot study, data will be summarized with descriptive statistics only; no formal comparisons will be performed. Findings will generate hypotheses for future research. Recruitment is planned over 18 months, with a total study duration of 24 months.
Ethical and administrative aspects
The study adheres to Good Clinical Practice, the Declaration of Helsinki, and EU/national regulations. Ethical approval is required before initiation. Participants must provide written informed consent for both study participation and data processing. Data will be handled in compliance with GDPR, using pseudonymization, secure storage, and restricted access. Authorized monitors and regulatory authorities may inspect source documents. Biologic samples will be stored until completion of analyses. Results will be published in aggregated, non-identifiable form in scientific journals and conferences.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Studies focusing on the presence of immunocompetent cells at barrier sites (intestinal lamina propria, lungs, and skin) have shown that, at the intestinal level, diet and metabolism can influence the phenotype of Th17 lymphocytes. Indeed, dietary enrichment in short-chain fatty acids can promote differentiation toward Treg, whereas the habitual dietary intake of long-chain fatty acids, as well as higher salt consumption, is associated with an increased number of lymphocytes with a Th17 functional profile, and thus with a state of autoimmunity. Barrier sites are typically rich in TRM (tissue-resident memory T) cells, which display site-specific functional profiles tailored to local homing requirements. In the skin, TRM are characterized by high expression of CCR4, CCR10, CXCR4, GATA6, and BCL6. In contrast, the TEM (T effector memory) and TEMRA (terminally differentiated effector memory) compartments appear to share a functional profile across different barrier sites and peripheral tissues.
However, the classification of barrier-site T cells into Th1, Th17, and Th2 subtypes should be viewed in a nuanced way-as an expression of functional characteristics rather than the final outcome of a maturation and differentiation process. In particular, Th17 lymphocytes can modify their functional phenotype, exhibiting distinct transcriptional profiles associated with either homeostatic or pathogenic potential, suggesting that these should be considered tissue-dependent functional states rather than different cell types. Th17 lymphocytes are associated with secretion of IL-17A, IL-17F, and IL-22, and depend on the RORγt-dependent signaling pathway, while TGF-β and IL-6 are required for their generation from naïve T lymphocytes. Studies on the involvement of immune components in the etiopathogenesis of SD have so far focused on the skin, where a role for γδ T cells has been observed, with secretion of IL-1α, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12, IL-17, TNF-α, β-defensins-likely related to the maturation of dendritic cells induced by sebaceous lipids and the subsequent induction of the NLRP3 inflammasome.
Malassezia itself can induce the release of IL-1β in vitro by dendritic cells obtained from peripheral blood.
No studies are currently available on the possible involvement, in terms of functional modulation, of peripheral blood lymphomonocytes in the pathogenesis of SD.
Likewise, despite known dietary influences on Th17 cell function at barrier sites such as the intestinal mucosa, data are lacking regarding the role of diet and lifestyle in seborrheic dermatitis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Seborrheic Dermatitis (DS)
Participants aged 45-75 years with mild-to-moderate facial seborrheic dermatitis. Additional sebaceous areas may be affected. Blood samples are collected for plasma analysis (secretory and lipidomic profiling) and for lymphomonocyte isolation and flow cytometric phenotyping. Participants also complete a dietary habits questionnaire.
No interventions assigned to this group
Non-Affected Controls (NA)
Healthy volunteers aged 45-75 years with no seborrheic dermatitis or other relevant dermatologic diseases. Controls undergo the same laboratory and questionnaire procedures as the DS group.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Both sexes. Age 45-75 years. Treatments for SD, topical and/or systemic, suspended for at least two (2) weeks.
Willingness to comply with the appointments/procedures required by the study. Signature of the informed consent.
Exclusion Criteria
Diagnosed neurodegenerative diseases. Ongoing pharmacological treatment, topical or systemic, for Seborrheic Dermatitis (SD).
Immunosuppression. HIV seropositivity.
45 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
San Gallicano Dermatological Institute IRCCS
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
San Gallicano Dermatological Institute IRCCS
Roma, Italy, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RS 170/ISG/24
Identifier Type: -
Identifier Source: org_study_id